Skip to main content
Clinical Trials/NCT01978665
NCT01978665CompletedPhase 4

The Effect of Prednisone and Solu-Medrol on Physical Exercise in COPD Patients and the Inflammaroty Response During and After Exercis.

Bispebjerg Hospital1 site in 1 country14 target enrollmentStarted: April 2013Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
14
Locations
1
Primary Endpoint
effect on muscle power

Study Overview

Brief Summary

The objective of this study is to investigate if there is an effect on exercise performance og of the anti inflammatory drugs prednisone and solu-medrol in patints with chronic obstructive pulmonary disease(COPD)

Detailed Description

RCT study with 4 days of steroid

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • FEV1< 60% FEV1/FVC ratio <70 %
  • able to use a ergometer bike

Exclusion Criteria

  • Haemodynamicaly unstable heart conditions
  • exacerbations before 6 week entry of the study exacerbation during the study period treatment with beta blockers malignancy the last 5 years allergi toward IMP

Arms & Interventions

prednisone and Solumedrol

Placebo Comparator

placebo arm versus prednisone

Intervention: prednisone (Drug)

solumedrol

Placebo Comparator

placebo versus solu medrol

Intervention: prednisone (Drug)

placebo

Other

measurement of fitness

Intervention: prednisone (Drug)

Outcomes

Primary Outcomes

effect on muscle power

Time Frame: jan 2013 to july 2013 (6 months)

muscular strenght

Secondary Outcomes

  • the inflammatory response(jan 2013 to july 2013 (6 months))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vibeke Backer

professor

Bispebjerg Hospital

Study Sites (1)

Loading locations...

Similar Trials